A pro-oxidant microenvironment sustained by eNOS uncoupling seems to contribute to the survival of metastatic melanoma cells, since L-sepiapterin treatment reduced cell viability at 24, 48, 72, and 96 h as shown by MTT (Figure 8A) and clonogenic assay (Figure 8B). The gene discussed is NOS3; the disease is melanoma.